Citation
Ibraheem, Shahad Abdulwahhab
(2022)
Effectiveness of health-belief model-based intervention in improving knowledge, practices and awareness in utilizing a handheld-ultrasound-prototype among females with breast lumps.
Doctoral thesis, Universiti Putra Malaysia.
Abstract
Breast cancer is the most common malignancy among Malaysian women.
Females who tested positive for a lump on the Center of Diagnostic Nuclear
Imaging were initially randomly chosen. This study aims to assess the accuracy
of Prototype Handheld Ultrasound (HHUS) performance compared to Automated
Breast Ultrasound (ABUS), the gold standard, and Breast Self-Examination
(BSE), as well as the effectiveness of the Health Belief Module (HBM) - based
intervention modules to improve knowledge, practice, and awareness regarding
breast abnormalities. On the same day, all the participants went thru both
modalities and assessing the images of a breast lesion using the fifth edition BIRADS
lexicon characteristics. In a single-blinded randomized control study, they
were randomly allocated to the intervention and control group using a computer
random number generator. The intervention group was given access to a 20-
minute E-educational session. At baseline and one month after the intervention,
data were obtained using precise and reliable English and Malay questionnaires.
Kappas was used to evaluating the level of agreement among radiologists
regarding the BI-RADS lexicon. The data were examined using the SPSS 25.0
software. After that, the differences between the group and within-group effects
were assessed using McNemar’s test and chi square with P-values less than 0.05.
ABUS and prototype HHUS observers found the same number of breast lesions
in the 324 breasts of the 162 respondents. There was no significant difference in
the mean lesion size, with a maximum mean length dimension of 0.48±0.33cm.
The assessment of the lesion's shape, orientation, margin, echo pattern, posterior
acoustic features, and calcification of lesions was obtained with good to excellent
agreements between ABUS and HHUS observers (κ=0.70-1.0). Except for lesion
orientation P=0.00, there was no difference between the ABUS and prototype
HHUS. Diagnostic accuracy (99.8% and 97.7-98.9%), (99.5% and 98.0-99.0%),
specificity (99.8% and 99.6-99.8%), positive predictive value (98.1% and 90.3-
96.2%), and negative predictive value (90.0% and 84.4-88.7%), and areas under
the curve (0.98 and 0.83-0.92; P < 0.05) were not significantly different between
ABUS and prototype HHUS observers. Participants' BSE self-report findings and
the prototype HHUS had a significant positive correlation for lesion size (r = 0.62-
0.93), and this difference was significant (P 0.05). only 4 (0.6%) were malignant
as confirmed by histology 1.29 ±0.95(0.6-3.6cm) and the remaining lesions,
998(99.4%), had a mean length of 0.46±0.28(0.2-2.5cm) were benign. The
intervention group performed better than the control group in terms of postintervention
improvements in breast self-examination (BSE) and awareness about
breast cancer.
In terms of secondary outcomes, there were generally statistically significant
differences between the groups for the means of perceived susceptibility (P=000),
benefits of BSE (P<0.001), confidence of BSE (P=0.000) and health motivation
(P=0.000). There was no significant difference between the perceived
seriousness and BSE barriers subscales. Health motivation, confidence and
health motivation increased significantly more in the intervention group than in the
control group. Over a month, a within-group analysis revealed that the mean
health beliefs scores for BSE barriers (108.67 to 128.68, P<0.029), BSE
confidence (91.23 to 108.69, P=0.000), and health motivation (97.99 to 109.35,
P<0.005) increased in the HBM-based educational intervention group compared
to the control group. According to these findings, prototype HHUS is increased
sensitivity and had similar specificity compared with ABUS in the diagnosis of
breast abnormalities. Additionally, ABUS has similar performance to prototype
HHUS in women aged 18–59 years old. ABUS or HHUS is a suitable modality for
breast cancer diagnosis.
Download File
Additional Metadata
Actions (login required)
 |
View Item |